Skip to main content

Want a detailed portfolio tracker?

Skye Bioscience (SKYE) P/E (2018 - 2026)

Skye Bioscience (SKYE) P/E from Apr 2, 2018 to Jun 3, 2026. The TTM Skye Bioscience (SKYE) P/E is -0.44. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Skye Bioscience (SKYE)

YearP/EChange
2026-0.44+2.85%
2025-0.42-86.48%
2024-3.13+689.74%
2023-0.40-39.76%
2022-0.66-74.59%
2021-2.59+100.34%
2020-1.29-98.12%
2019-68.95+2386.39%
2018-2.77N/A

Comparison Skye Bioscience (SKYE) P/E with competitors

Skye Bioscience (SKYE) P/E is -0.44.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.39%
NBYStablecoin Development Corp0.10-123.48%
ENLVEnlivex Therapeutics Ltd0.15-134.50%
FGENFibroGen Inc0.24-155.13%
TRAWTraws Pharma Inc0.47-208.59%
FBIOFortress Biotech Inc0.71-262.16%
CHRSCoherus Biosciences Inc0.98-324.65%
ORMPOramed Pharmaceuticals Inc1.47-438.42%
AGENAgenus Inc2.05-570.48%
VIVSVivoSim Labs Inc2.54-682.41%
INVAInnoviva Inc3.19-832.32%
CRMDCorMedix Inc3.65-937.34%
ABEOAbeona Therapeutics Inc4.20-1065.80%
VXRTVaxart Inc4.26-1078.80%
CVACCureVac N.V.4.45-1121.06%
SRPTSarepta Therapeutics Inc4.62-1162.08%
GLPGGalapagos NV4.86-1215.97%
RIGLRigel Pharmaceuticals4.92-1229.91%
ZVRAZevra Therapeutics Inc4.97-1242.43%
ABUSArbutus Biopharma Corp5.69-1407.73%
CGENCompugen Ltd7.38-1795.94%
AUPHAurinia Pharmaceuticals Inc9.25-2224.88%
ACADAcadia Pharmaceuticals Inc9.59-2302.19%
OMEROmeros Corporation9.88-2370.04%
PLXProtalix BioTherapeutics Inc9.91-2375.94%
SPROSpero Therapeutics Inc10.73-2565.57%
ADMAAdma Biologics Inc11.33-2702.44%
SVASinovac Biotech Ltd11.44-2726.64%
TBPHTheravance Biopharma Inc11.78-2804.87%
HRMYHarmony Biosciences Holdings Inc12.18-2897.62%
TGTXTG Therapeutics Inc13.18-3127.08%
INCYIncyte Corp13.38-3173.61%
SABSSAB Biotherapeutics Inc14.06-3328.81%
XOMAXOMA Corp14.95-3532.65%
REGNRegeneron Pharmaceuticals Inc14.98-3540.69%
PBYIPuma Biotechnology Inc15.05-3556.81%
EXELExelixis Inc15.79-3727.79%
NAGENiagen Bioscience Inc16.35-3856.44%
CPRXCatalyst Pharmaceuticals Inc17.34-4083.78%
MDXGMimedx Group Inc17.38-4090.81%
ARGXArgen X SE23.07-5399.13%
HALOHalozyme Therapeutics Inc23.20-5428.76%
XOMAOXOMA Corp25.34-5921.25%
VRTXVertex Pharmaceuticals Inc25.66-5992.68%
XOMAPXOMA Corp25.67-5995.97%
CTMXCytomX Therapeutics Inc25.70-6002.35%
ASNDAscendis Pharma A/S26.35-6153.07%
RPRXRoyalty Pharma plc - Class A27.50-6415.21%
SLNOSoleno Therapeutics Inc29.02-6764.31%
LGNDLigand Pharmaceuticals Inc - Class B30.19-7033.31%
BMRNBiomarin Pharmaceutical Inc37.51-8714.76%
APLSApellis Pharmaceuticals Inc39.02-9062.48%
KRYSKrystal Biotech Inc39.70-9217.84%
GMABGenmab40.20-9334.06%
ONCBeiGene Ltd67.03-15494.92%
TECHBio-Techne Corp68.59-15855.09%
VCELVericel Corp80.63-18619.13%
PHARPharming Group N.V.87.74-20252.39%
ALNYAlnylam Pharmaceuticals Inc124.93-28795.09%
TLXTelix Pharmaceuticals Ltd139.89-32230.46%
CORTCorcept Therapeutics Inc158.39-36479.27%